Improved Ex-vivo Culture Of Keratinocytes For Clinical Applications
Funder
National Health and Medical Research Council
Funding Amount
$275,203.00
Summary
Skin cells grown for clinical applications currently require animal-derived cells and-or non-defined products for their expansion in the laboratory; these reagents can potentially infect patients who receive these therapies. This project will identify the essential components provided by these reagents and develop a fully synthetic and defined culture system. This improvement will provide safer, cost-effective grafts and cell-based therapies that will benefit patients suffering burns and wounds.
Regulation Of Leukocyte Lifespan By Granzyme B And PI-9
Funder
National Health and Medical Research Council
Funding Amount
$816,673.00
Summary
To fight infection or cancer the body produces specialized cells called cytotoxic lymphocytes (CLs) which target and eradicate abnormal cells. The number of CLs increases dramatically during infection, and decreases following infection. How this population decrease is controlled is not fully understood, but we propose that a protein used by the CL to kill targets also triggers suicide of the CL after it has destroyed a certain number of targets. How this is achieved is the focus of this project.
A Fundamental study into the role of the organic fraction on the toxicity of combustion generated airborne particles. Using a new set of analytical tools this project will for the first time allow a quantified measure of the toxicity of organic compounds condensed on the surface of airborne particles. Understanding the toxicity of particle pollution is essential in controlling the exposure risk to public health.